STROKE AND THROMBOLYTIC THERAPY AWARENESS AMONG MEDICAL STUDENTS: A CROSS-SECTIONAL STUDY AT DAI NAM UNIVERSITY, VIETNAM
Main Article Content
Abstract
Background: Stroke is a critical global health issue, consistently ranking as a leading cause of mortality and long-term disability. In Vietnam, while stroke units have expanded, public awareness and the timely use of advanced therapies remain significant challenges. This study aims to assess the awareness regarding stroke and thrombolytic therapy among medical students at Dai Nam University in 2024.
Methods: A cross-sectional descriptive study was conducted from November 2024 to March 2025 at Dai Nam University, Hanoi. Data were collected through a self-administered structured questionnaire. Descriptive statistics and SPSS version 25.0 were used for data analysis, with the Chi-square test employed to compare between pre-clinical and clinical groups.
Results: Among 228 medical students in the study, a vast majority of participants (97.4%) had previously heard of stroke, but only 46.1% were aware of thrombolytic therapy. Clinical students demonstrated significantly higher proficiency in identifying risk factors and warning signs, such as limb weakness (93.9%) and facial deviation (93.1%), compared to pre-clinical students (p < 0.05). Notably, only 19.7% of the total sample correctly identified the 4.5-hour "golden hour" window for thrombolysis. While 72.8% of students chose immediate emergency transport as the primary action, a small proportion (6.1%) still favored unscientific traditional practices.
Conclusion: The study highlights a substantial gap between general stroke awareness and specific knowledge of emergency interventions among medical students. While clinical training significantly improves symptom recognition, there is a need to enhance education regarding the time-sensitive nature of thrombolytic therapy. These results emphasize the necessity of updating medical curricula to include more focused training on acute stroke protocols and the 4.5-hour treatment window to improve future stroke care in Vietnam.
Article Details
Keywords
Stroke, Thrombolysis, Awareness, Medical Students, Dai Nam University.
References
[2] Feigin VL, Brainin M, Norrving B, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022. Int J Stroke. 2022;17(1):18-29. doi:10.1177/17474930211065917
[3] Feigin VL, Abate MD, Abate YH, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024;23(10):973-1003. doi:10.1016/S1474-4422(24)00369-7
[4] Scott CA, Li L, Rothwell PM. Diverging Temporal Trends in Stroke Incidence in Younger vs Older People: A Systematic Review and Meta-analysis. JAMA Neurol. 2022;79(10):1036-1048. doi:10.1001/JAMANEUROL.2022.1520
[5] Truyen TTTT, Vo NLY, Vo QP, et al. Burden and risk factors of stroke in Vietnam from 1990 to 2021 – a systematic analysis from global burden disease 2021. Journal of Stroke and Cerebrovascular Diseases. 2025;34(3):108241. doi:10.1016/J.JSTROKECEREBROVASDIS.2025.108241
[6] Tran MC, Prisco L, Pham PM, et al. Comprehensive analysis of stroke epidemiology in Vietnam: Insights from GBD 1990–2019 and RES-Q 2017–2023. Glob Epidemiol. 2025;9:100199. doi:10.1016/J.GLOEPI.2025.100199
[7] di Biase L, Bonura A, Caminiti ML, Pecoraro PM, Di Lazzaro V. Neurophysiology tools to lower the stroke onset to treatment time during the golden hour: microwaves, bioelectrical impedance and near infrared spectroscopy. Ann Med. 2022;54(1):2658-2671. doi:10.1080/07853890.2022.2124448
[8] Eissa A, Krass I, Bajorek B V. Barriers to the utilization of thrombolysis for acute ischaemic stroke. J Clin Pharm Ther. 2012;37(4):399-409. doi:10.1111/J.1365-2710.2011.01329.X
[9] Li S, Wangqin R, Pan Y, et al. Outcomes associated to the time to treatment with intravenous tenecteplase for acute ischaemic stroke: subgroup analysis of the TRACE-2 randomised controlled clinical trial. Stroke Vasc Neurol. 2024;9(6):613-622. doi:10.1136/SVN-2023-002694
[10] Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials. The Lancet. 2014;384(9958):1929-1935. doi:10.1016/S0140-6736(14)60584-5
[11] Pradhan RR, Jha A, Bhandari S, Ojha S, Karn R. Knowledge, attitude, and practice of stroke and thrombolysis among students preparing for undergraduate medical entrance examination in Kathmandu, Nepal. Health Sci Rep. 2021;4(2):e268. doi:10.1002/HSR2.268;ISSUE:ISSUE:DOI
[12] Khamaiseh AM, Habashneh SS. Prevalence and associated factors of non-communicable chronic diseases among university academics in Jordan. PLoS One. 2024;19(8):e0304829. doi:10.1371/JOURNAL.PONE.0304829
[13] Heikkilä I, Kuusisto H, Holmberg M, Palomäki A. Fast Protocol for Treating Acute Ischemic Stroke by Emergency Physicians. Ann Emerg Med. 2019;73(2):105-112. doi:10.1016/j.annemergmed.2018.07.019
[14] Kim M, Han C. Bloodletting for Acute Stroke Recovery: A Systematic Review and Meta-Analysis. Healthcare (Basel). 2024;12(20). doi:10.3390/HEALTHCARE12202060
[15] Group TNI of ND and S rt PSS. Tissue Plasminogen Activator for Acute Ischemic Stroke. New England Journal of Medicine. 1995;333(24):1581-1588. doi:10.1056/NEJM199512143332401